0001386560-23-000001.txt : 20230517 0001386560-23-000001.hdr.sgml : 20230517 20230516182537 ACCESSION NUMBER: 0001386560-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230516 EFFECTIVENESS DATE: 20230517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eureka Therapeutics, Inc. CENTRAL INDEX KEY: 0001386560 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 204354368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-481903 FILM NUMBER: 23929129 BUSINESS ADDRESS: STREET 1: 5858 HORTON ST STE 170 CITY: Emeryville STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 654-7045 MAIL ADDRESS: STREET 1: 5858 HORTON ST STE 170 CITY: Emeryville STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Eureka Therapeutics Inc DATE OF NAME CHANGE: 20070112 D 1 primary_doc.xml X0708 D LIVE 0001386560 Eureka Therapeutics, Inc. 5858 HORTON ST STE 370 Emeryville CA CALIFORNIA 94608 (510) 654-7045 DELAWARE Eureka Therapeutics Inc Corporation true Cheng Liu 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Executive Officer Director Michael Cannon 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Wai-Yan "Sandy" Chau 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Chih-Kai "C.K. Cheng 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Reed Jobs 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Jacqueline Northcut 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Marvin Samson 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director William S. Solari III 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Director Victor Shum 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Executive Officer Vivien Chan 5858 Horton Street, Suite 370 Emeryville CA CALIFORNIA 94608 Executive Officer Biotechnology Decline to Disclose 06b false true false true true true Convertible promissoy notes (Notes) that is convertible into Issuer capital stock (Note Stock), and shares of Note Stock into which the Notes may convert. false 0 20000000 0 20000000 false 0 0 0 0 false Eureka Therapeutics, Inc. Victor Shum Victor Shum General Counsel 2023-05-16